SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Beslut om HPV- vaccin rivs upp

By 1 Comment

Aftonbladet.se

Stockholm. Landstingens upphandling av vaccin mot livmoderhalscancer, HPV-vaccin, måste göras om. De beslutade kammarrätten i Stockholm på onsdagen. Orsaken är att landstingen angett en för lång avtalstid.

Vaccinet, som ska ges gratis till hundratusentals flickor, försenas nu ytterligare.

Läkemedelsjätten Glaxo Smith Kline (GSK) vann den nationella upphandlingen. Men det förlorande företaget Sanofi Pasteur MSD överklagade ända upp till kammarrätten.

Read more

Google translation Swedish-English

Stockholm. The county councils’ procurement of vaccines against cervical cancer, HPV vaccine, must be repeated. They decided Appeal in Stockholm on Wednesday. The reason is that the county entered a long-term.

The vaccine, which should be free to hundreds of thousands of girls, now delayed further.

Pharmaceutical giant GlaxoSmithKline (GSK) won the national award. But the losing company Sanofi Pasteur MSD appealed up to the appeal.

To improve drug safety, FDA should check its mixed-up files

By Leave a Comment

Boston.com March 20, 2011 FOLLOWING A number of high-profile drug safety scandals in recent years — such as Vioxx and Avandia — the pharmaceutical industry and the Food and Drug Administration are spending a great deal of energy trying to uncover, as early as possible, rare side effects that make a drug too risky. Sometimes, […]

Quarter Of Girls Missing Out On Life-Saving Vaccine: New Website Aims To Reverse Trend, Australia

By Leave a Comment

Medical News Today Article Date: 10 Mar 2011 – 0:00 PST Cancer Council Australia suggests an alarming lack of knowledge may be to blame for the fact that many girls aged 12-13 are not having the cervical cancer vaccine, despite it being available free of charge through schools under the Australian Government’s National HPV Vaccination […]

A tablet a day keeps the patient at bay: the health hazards of prevention – vaccinations and pharmacoprophylaxis BSEM conference 11th March 2011

By Leave a Comment

FoodsMatter.com ‘Do no harm! That’, said Dr David Freed, introducing the British Society of Environmental Medicine’s excellent conference which he had also organised, ‘is the charge put upon doctors when they qualify. But do they?’ The assumption is that the more medical care is available, the more good it will do but the facts do […]

CDC to Study Vaccines and Autism

By Leave a Comment

Huffingtonpost
David Kirby

Author/Journalist
Posted: March 18, 2011 05:46 PM

The Centers for Disease Control and Prevention wants to study autism as a possible clinical outcome of immunization, as part of its newly adopted 5-year research agenda for vaccine safety, the agency said on its website.

The CDC will also study mitochondrial dysfunction and the potential risk for post-vaccine “neurological deterioration,” and convene an expert panel on the feasibility of studying health outcomes such as autism among vaccinated and unvaccinated children.

The CDC plan adopts recommendations approved by the National Vaccine Advisory Committee of the US Department of Health and Human Services. It also comes one month after the federal government’s leading autism body, the Interagency Autism Coordinating Committee (IACC), announced a shift in research priorities toward environmental triggers for autism, which the IACC said could include toxins, biological agents and “adverse events following immunization.”

The Centers for Disease Control and Prevention’s Immunization Safety Office Scientific Agenda indentified the need to research “Neurodevelopmental disorders, including autism spectrum disorder (ASD)” as a possible clinical outcome of vaccination.

News

Videos

Contact